556.0000 -4.05 (-0.72%)
NSE Dec 29, 2025 15:31 PM
Volume: 50,360
 

556.00
-0.72%
Axis Direct
Considering overall stellar performance we have incresed earnings for FY22E & FY23E and increased target price to INR 1,670 with Buy recommendations.
Promoters unpledged 3.63% of shares in last quarter. Total pledge stands at 35.32% of promoter holdings
More from Solara Active Pharma Sciences Ltd.
Recommended